SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Neurocrine Biosciences (NBIX)
An SI Board Since July 1996
Posts SubjectMarks Bans Symbol
1834 74 0 NBIX
Emcee:  Billy Dunn Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
234 <. It sound like Cinderella story> Yea, she was in the seat next to me jLLCF-6/30/1999
233 gs: Actually, I do not like this kind on news. It sound like Cinderella story Miljenko Zuanic-6/30/1999
232 IL-12 (cytokines)as an antiangiogenesis agent old article, but worth posting. gao seng-6/29/1999
231 < The publication reports that in preclinical models of Kaposi's sarcomaLLCF-6/29/1999
230 <Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that a rLLCF-6/29/1999
229 Nature Medicine Publication Demonstrates IL-4 Fusion Toxin is Effective In Treagao seng-6/29/1999
228 Retirement fund manager, hasn't read anything beyond romance novels for 4 1scaram(o)uche-6/17/1999
227 <Well, we took some size> Well, so much for that, and another 100k tradeLLCF-6/17/1999
226 Well, we took some size out at $5 here with my bosses money... lets see if theyLLCF-6/16/1999
225 Bafort, as you asked, here is a potential competitor to NBIX for the glioblastoWWS-6/10/1999
224 I agree with some points made by Rick and Harry, with some of yours, but let meMiljenko Zuanic-6/9/1999
223 i agree market isnt that big BUT 1/ astrocytoma is a real killer as we know sudalroi-6/9/1999
222 Dalroi: Many, many thanks for the extra effort. Awfully hard-working crew herscaram(o)uche-6/9/1999
221 Thanks, Harry, good stuff. BTW, I've picked up a couple of very important scaram(o)uche-6/8/1999
220 While I also like NBIX as a CNS drug company, I see IL-4 as an important highNeuroInvestment-6/8/1999
219 >> Does this mean PH3 starts next year if FDA approves "fast track&qscaram(o)uche-6/8/1999
218 MZ: True, the astrocytoma market is small. However, the number of IL-4R positscaram(o)uche-6/8/1999
217 Thanks Stefaan. Data looks good, but I am not that excited. NBIX business is CMiljenko Zuanic-6/8/1999
216 DAK here is the original abstract "DI.09.03 Intratumoral IL-4 toxin treatdalroi-6/8/1999
215 Here's the entire press release: biz.yahoo.com Stock is up 6.5%....... foLLCF-6/8/1999
214 DAK collected another bunch of nbix today but this time the oct 5 is not goingdalroi-6/8/1999
213 It appears that the face of it that thalidomide is competition for IL-4 ["LLCF-6/8/1999
212 "These positive results support Neurocrine's decision to pursue and aLLCF-6/8/1999
211 Tuesday June 8, 9:03 am Eastern Time Company Press Release SOURCE: Neurocrinescaram(o)uche-6/8/1999
210 MZ, Dalroi: Much appreciated. Rick scaram(o)uche-6/8/1999
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News